Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREOB in early stage osteonecrosis of the femoral head
NCT02890537Phase 2Completed
- Sponsor
- Erasmus Hospital
- Start
- Oct 2003
- Primary completion
- May 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of PREOB in osteonecrosis of the femoral head (ONFH) (2 arms), sponsored by Erasmus Hospital. Primary endpoints: Percentage of responder subjects at 24 months and Potential occurrence of any AE or SAE at 60 months. Started Oct 2003; status: completed.
02
Drugs
PREOB
03
Conditions
osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on NCT02890537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02890537.